Chemical Structure : CDRI-1709S
Catalog No.: PC-27859Not For Human Use, Lab Use Only.
CDRI-1709S is a highly potent, selective small molecule AdipoR1 (Adiponectin receptor 1) agonist with EC50 of 414.7 pM, activates adiponectin signalling via AdipoR1 but not AdipoR2.
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
CDRI-1709S is a highly potent, selective small molecule AdipoR1 (Adiponectin receptor 1) agonist with EC50 of 414.7 pM, activates adiponectin signalling via AdipoR1 but not AdipoR2.
CDRI-1709S promoted C2C12 myoblast differentiation into mature myotubes, accompanied by increased expression of MyoD and myogenin.
CDRI-1709S also reverses Dexamethasone‐mediated impairments in oxidative and glycolytic capacity.
CDRI-1709S activated hallmark adiponectin‐associated signalling events, including phosphorylation of AMPK, AKT and p38‐MAPK, in AdipoR1‐overexpressing HEK293T and AdipoR‐rich C2C12 myotubes.
CDRI-1709S protected myotubes against Dexamethasone, LPS + TNFα and PBS (nutrient deficiency)‐induced atrophy.
CDRI-1709S prevented dexamethasone‐induced skeletal muscle atrophy in SD rats.
| M.Wt | 262.24 | |
| Formula | C15H11NaO3 | |
| Appearance | Solid | |
| Storage |
|
|
| Solubility |
10 mM in DMSO |
|
1. Md Rameez Moin, et al. J Cachexia Sarcopenia Muscle. 2026 Aug;17(4):e70328.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright